25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end

被引：0
|
作者：
Markus H. Heim
机构：
[1] University of Basel,Markus H. Heim is at the Department of Biomedicine, Switzerland and at the Division of Gastroenterology and Hepatology
[2] 4031 Basel,undefined
[3] University Hospital Basel,undefined
[4] 4031 Basel,undefined
[5] Switzerland.,undefined
来源：
Nature Reviews Immunology | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The mechanisms underlying the antiviral activity of type I interferons (IFNs) are still unclear, but IFNα has long been used in the treatment of chronic hepatitis C (CHC). While reviewing the history of IFNα-based CHC treatment, Markus H. Heim highlights the remaining questions and discusses the future challenges of IFN-based therapies.
引用
收藏
页码：535 / 542
页数：7
相关论文
共 50 条
  • [1] 25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end
    Heim, Markus H.
    NATURE REVIEWS IMMUNOLOGY, 2013, 13 (07) : 535 - 542
  • [2] Interferon-based treatment of chronic hepatitis C
    Souvignet, Claude
    Lejeune, Olivier
    Trepo, Christian
    BIOCHIMIE, 2007, 89 (6-7) : 894 - 898
  • [3] Interferon-based treatment of chronic hepatitis D
    Sandmann, Lisa
    Wedemeyer, Heiner
    LIVER INTERNATIONAL, 2023, 43 : 69 - 79
  • [4] Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
    Camelia Sultana
    Gabriela Opri?an
    Monica Delia Teleman
    Sorin Dinu
    HepGen 88/2012 Project Team
    Cristiana Oprea
    Mihai Voiculescu
    Simona Ruta
    World Journal of Gastroenterology, 2016, (37) : 8406 - 8413
  • [5] Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
    Sultana, Camelia
    Oprisan, Gabriela
    Teleman, Monica Delia
    Dinu, Sorin
    Oprea, Cristiana
    Voiculescu, Mihai
    Ruta, Simona
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8406 - 8413
  • [6] Treatment of chronic hepatitis c with consensus interferon in relapsers and non-responders to interferon-based therapy
    Steffen, M.
    Cornberg, M.
    Buggisch, P.
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2368 - 2372
  • [7] Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment
    Hajarizadeh, Behzad
    Grebely, Jason
    McManus, Hamish
    Estes, Chris
    Razavi, Homie
    Gray, Richard T.
    Alavi, Maryam
    Amin, Janaki
    McGregor, Skye
    Sievert, William
    Thompson, Alexander
    Dore, Gregory J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (01) : 229 - 236
  • [8] BASELINE AND IN-TREATMENT BIOMARKERS FOR RESPONSE TO INTERFERON-BASED THERAPY IN CHRONIC HEPATITIS C
    Casrouge, A.
    Sultanik, P.
    Pol, S.
    Mallet, V.
    Albert, M. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S322 - S322
  • [9] Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals
    Alexopoulou, Alexandra
    Karayiannis, Peter
    ANNALS OF GASTROENTEROLOGY, 2015, 28 (01): : 55 - 65
  • [10] Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit
    Vafiadis, Irene
    Trilianos, Panagiotis
    Vlachogiannakos, Jiannis
    Karagiorga, Markisia
    Hatziliami, Antonia
    Voskaridou, Ersi
    Ladas, Spiros D.
    ANNALS OF HEPATOLOGY, 2013, 12 (04) : 364 - 370
12345